A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
- PMID: 40639372
- DOI: 10.1016/j.chembiol.2025.06.005
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
Abstract
Aberrant NLRP3 (NACHT-, leucine-rich repeat [LRR]- and pyrin domain [PYD]- containing protein 3) inflammasome activation is linked to many inflammatory diseases, driving the search for therapeutics inhibiting this pathway. NEK7 is proposed to mediate NLRP3 inflammasome assembly and activation by bridging adjacent NLRP3 subunits. Hence, reduction of NEK7 protein may block NLRP3 activation. We identified NK7-902, a potent and selective cereblon (CRBN) glue degrader of NEK7. NK7-902 degraded NEK7 in human immune cells and whole blood. However, full NEK7 degradation completely blocked NLRP3-dependent interleukin-1β (IL-1β) release in vitro only in certain donors and experimental conditions. Unlike most CRBN glue degraders, NK7-902 effectively degraded NEK7 in murine cells and inhibited IL-1β release in mouse in vivo. By contrast, oral administration of NK7-902 in cynomolgus monkey caused long-lasting NEK7 degradation but only transiently blocked IL-1β in blood. These findings suggest NEK7 contributes to but is not absolutely required for NLRP3 activation in monkeys and humans.
Keywords: CRBN; NEK7; NLRP3 inflammasome; inflammation; molecular glue degrader.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests All authors except Y.C.G., S.D., A.N.R.W., T.W., and J.K.-D. are past or current employees and shareholders of Novartis. Some of the authors have patents related to this work: US2020/16143 (F.M and A.C.) and US2020/361898 (C.J.F.). J.K.-D. received speaker fees, honoraria, and research grant support from Novartis and SOBI. T.W. has given invited talks for Novartis without a personal honorarium.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous